# Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis

> **NCT02125253** · PHASE3 · COMPLETED · sponsor: **Amneal Pharmaceuticals, LLC** · enrollment: 811 (actual)

## Conditions studied

- Seasonal Allergic Rhinitis

## Interventions

- **DRUG:** Mometasone Furoate Nasal Spray, 50 mcg
- **DRUG:** Nasonex Nasal Spray, 50 mcg
- **DRUG:** Placebo Nasal Spray

## Key facts

- **NCT ID:** NCT02125253
- **Lead sponsor:** Amneal Pharmaceuticals, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2014-03
- **Final completion:** 2014-06
- **Target enrollment:** 811 (ACTUAL)
- **Last updated:** 2015-11-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02125253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02125253, "Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02125253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*